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Wednesday, February 19, 2014 775aDCM-causing mutation ACTC E361G uncouples this relationship. Here, we
determine whether this also happens in heart muscle myofibrils producing iso-
metric force. We know that TnI and MyBP-C phosphorylation levels are high
in normal mouse heart (1.1 mol Pi/mol TnI). To reduce the phosphorylation
level of TnI and MyBP-C, mice were injected with a high dose of propranolol
which reduced of both TnI bisphosphorylation and MyBP-C phosphorylation
by at least 95%. Then we measured contraction in single myofibrils with a
Ca2þ-jump protocol using a range of Ca2þconcentrations. The Ca2þ-sensitivity
of isometric force and the kinetics of tension development and relaxation for
the ACTC E361G TG mouse myofibrils were compared with WT. Modulation
of the Ca2þ-sensitivity by changes in sarcomere length and by the Ca2þ-sensi-
tizer EMD 57033 was further investigated.
The maximum isometric force and the tension development rate was the same
for phosphorylated and dephosphorylated WT and ACTC E361G mouse myo-
fibrils. The ACTC E361Gmyofibrils had higher Ca2þ-sensitivity of force devel-
opment then WT. Despite that, the magnitude of length dependent activation
was well preserved in ACTC E361G myofibrils. Essentially, while the Ca2þ-
sensitivity of isometric force was increased 1.4-fold when WT myofibrils
were dephosphorylated, the ACTC E361G Ca2þ-sensitivity was not altered
by dephosphorylation. Additionally, comparing dephosphorylated WT vs
WT, the relaxation rate was 1.3-fold slower but dephosphorylation did not
change the kinetics of E361G myofibril. Changes in Ca2þ-sensitivity were
correlated with changes in relaxation rate. Thus the ACTC E361G mutation
uncoupled Ca2þ-sensitivity and lusitropy from the level of TnI and MyBP-C
phosphorylation in intact myofibrils.
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The sarcomere is the functional unit of the heart. Alterations in sarcomere acti-
vation lead to disease states such as hypertrophic and restrictive cardiomyopa-
thy (HCM/RCM). HCM is the most common monogenic cardiovascular
disease, affecting 1:500 and is the leading cause of death in young athletes.
Mutations in many of the sarcomeric genes are causal for HCM. In most cases,
these mutations result in increased calcium sensitivity of the sarcomere giving
rise to altered systolic and diastolic function. We show here that sarcomere
neutralization therapy, with the calcium desensitizer W7, is a potential thera-
peutic strategy for HCM/RCM. W7 has previously been shown to decrease
calcium sensitivity of the sarcomere through binding to cTnC and altering
cTnI-cTnC interactions. Acute treatment of adult cardiac myocytes with W7
caused a dose-dependent (1-10 mM) decrease in contractility, independent of
calcium transient changes. Alkalosis was used as an acute model of heightened
calcium sensitivity, resulting in increased contractility and decreased baseline
sarcomere length. Treatment with W7 in alkalosis remediated both phenotypes.
R193H cTnI transgenic (Tg) myocytes were used as a model of RCM. R193H
cTnI Tg myocytes display significant decreased baseline sarcomere length and
slowed relaxation. Acute treatment with W7 dose-dependently increased base-
line sarcomere length and remediated the slowed relaxation. Langendorff
perfused whole heart pacing stress was used to study W7 effects at the organ
level. R193H cTnI transgenic hearts had elevated end diastolic pressures at
all stimulation frequencies compared to nontransgenic mice. Acute treatment
with W7 restored normal end diastolic pressures throughout pacing in
R193H cTnI transgenic mice. These results provide evidence that drug-based
sarcomere neutralization therapy is a potential new approach to remediate
hyper-calcium sensitive sarcomere function evident in acquired (respiratory
alkalosis) and inherited (HCM/RCM) cardiac diseases.
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Protein kinase C phosphorylation of S43/45 on cardiac troponin I (cTnI) in-
creases during periods of cardiac stress to modulate cardiac myocyte contractile
performance, but the functional impact of this phosphorylation remains con-
troversial. Adenoviral gene transfer of phosphomimetic cTnIS43D, cTnIS45D
or cTnIS43/S45D into adult rat myocytes produced partial replacement and
non-additive alterations in contractile function 2 days after gene transfer.
More extensive replacement of endogenous cTnI is observed by 4 days along
with an adaptive functional response in the form of accelerated shorteningand re-lengthening. The present study focused on identifying the adaptive
responses observed in myocytes expressing these phospho-mimetic cTnI sub-
stitutions. Adaptations due to intramolecular communication within cTnI
were investigated by measuring cTnIS23/24 phosphorylation in myocytes ex-
pressing cTnI with S43D, S45D, and S43/45D. Increased expression of these
phosphomimetics elevated cTnIS23/24 phosphorylation compared to controls.
Western blot analysis also indicated intermolecular interactions contributed to
this adaptive response, as phosphorylation of S282 on cardiac myosin binding
protein C (cMyBP-C) and S16 on phospholamban (PLB) increased signifi-
cantly in myocytes. The increased PLB phosphorylation correlated with
changes in Ca2þ cycling observed in these myocytes compared to controls.
Additional studies performed under acidotic stress produced similar changes
in the phosphorylation of cTnIS23/24. Ongoing studies are testing whether
similar changes in cMyBP-CS282 develop with acidosis. The underlying
signaling mechanism responsible for this change in phosphorylation turnover
is currently under investigation. Overall, these results suggest cTnI substitu-
tions and cellular stress initiate intramolecular and intermolecular communica-
tion to generate an adaptive myofilament response. The shared response
produced by cTnI substitutions and cellular acidosis suggests this communica-
tion may be important for understanding the myofilament response under con-
ditions of contractile dysfunction.
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Missense mutations in the TNNC1 gene encoding cardiac and slow skeletal
troponin C (c/ssTnC) are associated with phenotypic outcomes of hypertrophic
cardiomyopathy (HCM). Since the impact of HCM c/ssTnC mutations during
skeletal muscle development and function is unknown, we addressed whether
changes in the myosin heavy chain (MHC) isoforms can occur outside of the
heart. We hypothesized that the ratio of MHC I to MHC II in various skeletal
muscles change due to an HCM-associated c/ssTnC A8V mutation in a knock-
in homozygous mouse (KI-TnC-A8Vþ/þ). The distribution of MHC I/II iso-
forms in diaphragm (D), soleus (S), tibialis anterior (TA), extensor digitorum
longus (EDL) and quadriceps (Q) isolated from 3- and 9-month (mo) old
male WT and KI-TnC-A8Vþ/þ mice were analyzed by glycerol SDS-PAGE.
The muscle/body weight ratio (M/BW) and running capacity were also
measured. At 3 mo, MHC isoform switching was observed in D (increased
MHCIIb), S (decreased MHCIIa, increased MHCI) and EDL (increased
MHCIIa/x, decreased MHCIIb) of KI-TnC-A8Vþ/þ compared to WT. TA M/
BW is increased in 3- and 9-mo KI-TnC-A8Vþ/þ mice compared to WT at
the same age. Pairwise comparison of M/BW from 3- vs 9-mo KI-TnC-
A8Vþ/þ mice showed a significant decrease for TA and Q and an increase
for EDL, and no change for any WT muscles. In running tests, KI-TnC-
A8Vþ/þ mice had a lower capacity to run distances compared to WT (281 vs
413 meters). Thus, changes in MHC isoforms in the skeletal muscles of mice
expressing c/ssTnC A8V are associated with reduced exercise endurance, sug-
gesting that skeletal muscle remodeling may contribute to the development
of HCM phenotype. Future studies will examine MHC isoforms at 9 mo
and Ca2þ-activated myofibrilar Mg2þ-ATPase rates from skeletal muscles in
KI-TnC-A8Vþ/þ mice.
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Rationale: Cardiac myosin binding protein-C (cMyBP-C) has three phosphor-
ylatable serines at N-terminus (Ser-273, Ser-282, and Ser-302) and phosphor-
ylation states of these serines may alter the thick filament structure and
function. Phosphorylation of these serines in cMyBP-C may also alter sarco-
mere length-dependent modulation of contractile force development (LDA),
which would be expected to modulate the Frank-Starling Law of the Heart.
Objective: To analyze length dependent activation in cMyBP-C for nonphos-
phorylated and phosphomimetic states of serines 273, 282, 302 and to study
the contribution of cMyBP-C in regulating cardiac contraction at different
sarcomere lengths.
Methods & Results: We studied the force-Ca2þ relationship in skinned myo-
cytes isolated from (a) nonphosphorylated alanine transgenic mice (cMyBP-
CAAA), (b) phosphomimetic aspartic acid transgenic mice (cMyBP-CDDD),
and normal cMyBP-CWT mice at 2.0 and 2.3 mm sarcomere length (SL).
At short SL, Ca2þ sensitivity was similar in all groups. However, Ca2þ sensi-
tivity was increased in the cMyBP-CAAA group compared to either the WT or
